Long-term safety and real-world effectiveness of fingolimod in relapsing multiple sclerosis

Long-term safety and real-world effectiveness of fingolimod in relapsing multiple sclerosis

Charlotte Druart, Souraya El Sankari, Vincent van Pesch Neurology Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium Abstract: With a growing number of disease-modifying therapies becoming available for relapsing multiple sclerosis...

Full description

Bibliographic Details
Main Authors: Druart C, El Sankari S, van Pesch V
Format: Article
Language:English
Published: Dove Medical Press 2017-12-01
Series:Patient Related Outcome Measures
Subjects:
Multiple Sclerosis
fingolimod
quality of life
safety
effectiveness
long-term
real-world evidence
patient-reported outcomes
Online Access:https://www.dovepress.com/long-term-safety-and-real-world-effectiveness-of-fingolimod-in-relapsi-peer-reviewed-article-PROM

Internet

https://www.dovepress.com/long-term-safety-and-real-world-effectiveness-of-fingolimod-in-relapsi-peer-reviewed-article-PROM

Similar Items